202 related articles for article (PubMed ID: 22069305)
21. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
[TBL] [Abstract][Full Text] [Related]
22. Bifunctional Gd(III) and Tb(III) chelates based on a pyridine-bis(iminodiacetate) platform, suitable optical probes and contrast agents for magnetic resonance imaging.
Laurent S; Vander Elst L; Galaup C; Leygue N; Boutry S; Picard C; Muller RN
Contrast Media Mol Imaging; 2014; 9(4):300-12. PubMed ID: 24706614
[TBL] [Abstract][Full Text] [Related]
23. A novel one-step synthesis of Gd3+-incorporated mesoporous SiO2 nanoparticles for use as an efficient MRI contrast agent.
Shao YZ; Liu LZ; Song SQ; Cao RH; Liu H; Cui CY; Li X; Bie MJ; Li L
Contrast Media Mol Imaging; 2011; 6(2):110-8. PubMed ID: 21504064
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of High Relaxivity Gadolinium AAZTA Tetramers as Building Blocks for Bioconjugation.
Tripepi M; Capuana F; Gianolio E; Kock FVC; Pagoto A; Stefania R; Digilio G; Aime S
Bioconjug Chem; 2018 Apr; 29(4):1428-1437. PubMed ID: 29470084
[TBL] [Abstract][Full Text] [Related]
25. Gadolinium(III) di- and tetrachelates designed for in vivo noncovalent complexation with plasma proteins: a novel molecular design for blood pool MRI contrast enhancing agents.
Martin VV; Ralston WH; Hynes MR; Keana JF
Bioconjug Chem; 1995; 6(5):616-23. PubMed ID: 8974462
[TBL] [Abstract][Full Text] [Related]
26. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
Chan MH; Lin HM
Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
[TBL] [Abstract][Full Text] [Related]
27. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
[TBL] [Abstract][Full Text] [Related]
28. PEG-coated and Gd-loaded fluorescent silica nanoparticles for targeted prostate cancer magnetic resonance imaging and fluorescence imaging.
Jiang W; Fang H; Liu F; Zhou X; Zhao H; He X; Guo D
Int J Nanomedicine; 2019; 14():5611-5622. PubMed ID: 31413566
[No Abstract] [Full Text] [Related]
29. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
[TBL] [Abstract][Full Text] [Related]
30. Acute Toxicity Evaluation of Glycosylated Gd
Mehravi B; Alizadeh AM; Khodayari S; Khodayari H; Ashtari K; Mohseni M; Anaraki NI; Dana EA; Safari S; Amanlou M
Mol Imaging Biol; 2017 Aug; 19(4):522-530. PubMed ID: 27957646
[TBL] [Abstract][Full Text] [Related]
31. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
[TBL] [Abstract][Full Text] [Related]
32. Copper-doped mesoporous silica nanospheres, a promising immunomodulatory agent for inducing osteogenesis.
Shi M; Chen Z; Farnaghi S; Friis T; Mao X; Xiao Y; Wu C
Acta Biomater; 2016 Jan; 30():334-344. PubMed ID: 26596565
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
[TBL] [Abstract][Full Text] [Related]
34. Cleavable β-cyclodextrin nanocapsules incorporating Gd(III)-chelates as bioresponsive MRI probes.
Martinelli J; Fekete M; Tei L; Botta M
Chem Commun (Camb); 2011 Mar; 47(11):3144-6. PubMed ID: 21270985
[TBL] [Abstract][Full Text] [Related]
35. Paramagnetic hollow silica nanospheres for in vivo targeted ultrasound and magnetic resonance imaging.
An L; Hu H; Du J; Wei J; Wang L; Yang H; Wu D; Shi H; Li F; Yang S
Biomaterials; 2014 Jul; 35(20):5381-5392. PubMed ID: 24703718
[TBL] [Abstract][Full Text] [Related]
36. In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.
Xu R; Wang Y; Wang X; Jeong EK; Parker DL; Lu ZR
Exp Biol Med (Maywood); 2007 Sep; 232(8):1081-9. PubMed ID: 17720954
[TBL] [Abstract][Full Text] [Related]
37. Gadolinium-Decorated Silica Microspheres as Redox-Responsive MRI Probes for Applications in Cell Therapy Follow-Up.
Muñoz Úbeda M; Carniato F; Catanzaro V; Padovan S; Grange C; Porta S; Carrera C; Tei L; Digilio G
Chemistry; 2016 Jun; 22(23):7716-20. PubMed ID: 27037861
[TBL] [Abstract][Full Text] [Related]
38. Enhancing transversal relaxation for magnetite nanoparticles in MR imaging using Gd³+- chelated mesoporous silica shells.
Huang CC; Tsai CY; Sheu HS; Chuang KY; Su CH; Jeng US; Cheng FY; Su CH; Lei HY; Yeh CS
ACS Nano; 2011 May; 5(5):3905-16. PubMed ID: 21513334
[TBL] [Abstract][Full Text] [Related]
39. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling.
Digilio G; Menchise V; Gianolio E; Catanzaro V; Carrera C; Napolitano R; Fedeli F; Aime S
J Med Chem; 2010 Jul; 53(13):4877-90. PubMed ID: 20533827
[TBL] [Abstract][Full Text] [Related]
40. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
Carniato F; Tei L; Cossi M; Marchese L; Botta M
Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
